Literature DB >> 11029504

Urokinase type plasminogen activator and its receptor regulate the invasive potential of gastric cancer cell lines.

Y Okusa1, T Ichikura, H Mochizuki, N Shinomiya.   

Abstract

To assess the role of urokinase-type plasminogen activator (uPA) and uPA receptor (uPAR) on the invasive potential of cancer cells, in vitro experiments were performed using two human gastric cancer cell lines, NUGC-3 and MKN-28. NUGC-3 cells secreted a higher level of uPA than MKN-28 cells, while the uPAR expression of NUGC-3 cells was lower than that of MKN-28 cells. Both cancer cell lines expressed Met protein and did not express hepatocyte growth factor (HGF). In Matrigel invasion assay, MKN-28 cells demonstrated significantly lower invasion index than NUGC-3 cells. The addition of exogenous uPA significantly increased the invasive activity of MKN-28 cells. The uPA expression in NUGC-3 cells was enhanced by adding conditioned media of fibroblast cells or HGF. These results suggest that uPA promotes the invasive capacity of the uPAR-positive cancer cells, and that stromal cells may play an important role in cancer cell invasion by supplying uPA and/or promoting uPA production.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11029504     DOI: 10.3892/ijo.17.5.1001

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

1.  Expression of urokinase-type plasminogen activator and its receptor in gastric fibroblasts and effects of nonsteroidal antiinflammatory drugs and prostaglandin.

Authors:  Junichi Iwamoto; Kimiko Takahashi; Yuji Mizokami; Toshiya Otsubo; Syuuhei Miura; Toshiaki Narasaka; Hiroki Takeyama; Takayuki Omata; Kouichi Shimokoube; Takeshi Matsuoka
Journal:  Dig Dis Sci       Date:  2003-12       Impact factor: 3.199

2.  Positive VEGF immunostaining independently predicts poor prognosis in curatively resected gastric cancer patients: results of a study assessing a panel of angiogenic markers.

Authors:  Oscar Vidal; Antonio Soriano-Izquierdo; Manuel Pera; José I Elizalde; Antonio Palacín; Antoni Castells; Josep M Piqué; Alain Volant; Jean P Metges
Journal:  J Gastrointest Surg       Date:  2007-10-31       Impact factor: 3.452

3.  Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting β‑catenin signaling.

Authors:  Juthika Kundu; S M Riajul Wahab; Joydeb Kumar Kundu; Yoon-La Choi; Ozgur Cem Erkin; Hun Seok Lee; Sang Gyu Park; Young Kee Shin
Journal:  Int J Oncol       Date:  2012-06-12       Impact factor: 5.650

4.  Hepatocyte growth factor/c-met signaling in regulating urokinase plasminogen activator in human stomach cancer: A potential therapeutic target for human stomach cancer.

Authors:  Kyung Hee Lee; Eun Young Choi; Myung Soo Hyun; Byung Ik Jang; Tae Nyeun Kim; Sang Woon Kim; Sun Kyo Song; Jung Hye Kim; Jae-Ryong Kim
Journal:  Korean J Intern Med       Date:  2006-03       Impact factor: 2.884

5.  MET4 expression predicts poor prognosis of gastric cancers with Helicobacter pylori infection.

Authors:  Naoko Sakamoto; Hironori Tsujimoto; Risa Takahata; Brian Cao; Ping Zhao; Nozomi Ito; Hideyuki Shimazaki; Takashi Ichikura; Kazuo Hase; George F Vande Woude; Nariyoshi Shinomiya
Journal:  Cancer Sci       Date:  2017-03       Impact factor: 6.716

6.  Osteopontin splice variants differentially exert clinicopathological features and biological functions in gastric cancer.

Authors:  Xiaojian Tang; Jianfang Li; Beiqin Yu; Liping Su; Yingyan Yu; Min Yan; Bingya Liu; Zhenggang Zhu
Journal:  Int J Biol Sci       Date:  2012-12-20       Impact factor: 6.580

7.  CRISPR/Cas9 nickase mediated targeting of urokinase receptor gene inhibits neuroblastoma cell proliferation.

Authors:  Karina D Rysenkova; Ekaterina V Semina; Maxim N Karagyaur; Anna A Shmakova; Daniyar T Dyikanov; Petr A Vasiluev; Yury P Rubtsov; Kseniya A Rubina; Vsevolod A Tkachuk
Journal:  Oncotarget       Date:  2018-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.